StockWatch
·
Specialty Chemicals
Quarterly Result2 Nov 2026, 01:51 pm

Epigral Ltd Declares Un-Audited Q2 FY27 Results

AI Summary

Epigral Limited announced the outcome of its Board Meeting held on November 2, 2026. The Board approved and took on record the Un-Audited Financial Results (Standalone & Consolidated) for the Second Quarter and Half Year ended September 30, 2026. The Limited Review Report from statutory auditors M/s. S R B C & CO LLP was also noted. The meeting took place at the company's registered office in Ahmedabad.

Key Highlights

  • Board meeting held on November 2, 2026.
  • Un-audited financial results for Q2 and H1 FY27 approved.
  • Standalone and consolidated results were declared.
  • Limited Review Report from auditors was taken on record.